An overview of the biological disease modifying drugs available for arthritic conditions in South Africa
The past decade has seen a major change in the treatment options and strategies for rheumatoid arthritis (RA) and the other immune-mediated arthritic diseases. The disease modifying antirheumatic drugs (DMARDs) are now used in early stages of the disease in order to preserve joint architecture. Ther...
Saved in:
Main Authors: | Leonie Harmse, Helmuth Reuter |
---|---|
Format: | article |
Language: | EN |
Published: |
AOSIS
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/1248f4fe9d1e473a9708a3ac6323da8f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012) -
Management of chronic ocular sarcoidosis: challenges and solutions
by: Matsou A, et al.
Published: (2018) -
Biological evaluation of novel 6-Arylbenzimidazo [1,2-c] quinazoline derivatives as inhibitors of LPS-induced TNF- alpha secretion
by: GALARCE,GLORIA D, et al.
Published: (2008) -
The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
by: Georgios Kokolakis, et al.
Published: (2021) -
Immunological strategy for detecting the pro-inflammatory cytokine TNF-alpha in salmonids
by: Rojas,Verónica, et al.
Published: (2012)